Respiratory/Pulmonary Market Research Reports & Industry Analysis
Respiratory/Pulmonary Industry Research & Market Reports
-
Europe Respiratory Protective Equipment Market Databank
... to 2029. Air-Purifying Respirators (APR) segment is expected to be the highest contributor to this market, with $9,163.2 Million in 2020, and is anticipated to reach $12,592.6 Million by 2029, registering a CAGR of 3.64%. ... Read More
-
Leading Respiratory Protective Equipment End User Markets Databank
... from 2021 to 2029. Healthcare segment is expected to be the highest contributor to this market, with $8,070.9 Million in 2020, and is anticipated to reach $11,029.1 Million by 2029, registering a CAGR of 3.57%. ... Read More
-
Global Respiratory Protective Equipment Market Databank
... to 2029. Air-Purifying Respirators (APR) segment is expected to be the highest contributor to this market, with $9,163.2 Million in 2020, and is anticipated to reach $12,592.6 Million by 2029, registering a CAGR of 3.64%. ... Read More
-
Leading Respiratory Protective Equipment Country Markets Databank
... 2021 to 2029. North America is expected to be the highest contributor to this market, with $5,372.6 Million in 2020, and is anticipated to reach $7,088.5 Million by 2029, registering a CAGR of 3.16%. Asia-Pacific ... Read More
-
Europe Cystic Fibrosis Therapeutics Market Databank
... to 2029. Hospital segment is expected to be the highest contributor to this market, with $3,622.8 Million in 2020, and is anticipated to reach $4,436.7 Million by 2029, registering a CAGR of 2.32%. Retail pharmacies ... Read More
-
Leading Cystic Fibrosis Therapeutics Country Markets Databank
... 2021 to 2029. Asia-Pacific is expected to be the highest contributor to this market, with $3,196.0 Million in 2020, and is anticipated to reach $4,216.6 Million by 2029, registering a CAGR of 3.16%. Asia-Pacific and ... Read More
-
Asia-Pacific Cystic Fibrosis Therapeutics Market Databank
... to 2029. Hospital segment is expected to be the highest contributor to this market, with $3,622.8 Million in 2020, and is anticipated to reach $4,436.7 Million by 2029, registering a CAGR of 2.32%. Retail pharmacies ... Read More
-
Leading Cystic Fibrosis Therapeutics Treatment Markets Databank
... 2021 to 2029. Route of Administration segment is expected to be the highest contributor to this market, with $2,818.1 Million in 2020, and is anticipated to reach $3,481.8 Million by 2029, registering a CAGR of ... Read More
-
USA Nasal Decolonization Market Insights, Forecast to 2028
... 105.76 million by the end of 2028, growing at a CAGR of 7.49% during 2022-2028. USA Nasal Decolonization Scope and Segment Nasal Decolonization market is segmented by type, and by application. Players, stakeholders, and other ... Read More
-
Pulmonary Embolism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Pulmonary Embolism (Cardiovascular) pipeline landscape. Pulmonary embolism is the sudden blockage of a major blood vessel (artery) in the ... Read More
-
Ventilator Associated Pneumonia (VAP) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Ventilator Associated Pneumonia (VAP) (Infectious Disease) pipeline landscape. Ventilator-associated pneumonia (VAP) is pneumonia that develops ... Read More
-
Community Acquired Pneumonia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Community Acquired Pneumonia (Infectious Disease) pipeline landscape. Community-acquired pneumonia (CAP) is defined as pneumonia acquired outside a ... Read More
-
Acute Respiratory Distress Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Acute Respiratory Distress Syndrome (Respiratory) pipeline landscape. Acute respiratory distress syndrome (ARDS) occurs when fluid ... Read More
-
Hospital Acquired Pneumonia (HAP) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Hospital Acquired Pneumonia (HAP) (Infectious Disease) pipeline landscape. Hospital Acquired Pneumonia (HAP) is defined as ... Read More
-
Cardiac Monitoring Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Cardiovascular Devices, Multi-Parameter ECG Monitors, Patient Monitoring Devices, Ambulatory Cardiac Monitoring, and Cardiac Monitors), Product Type (Portable Monitor, Smart Wearable Monitor, and Standard Monitor), Application (Coronary Heart Diseases, Sudden Cardiac Arrest, Stroke, Arrhythmia, Congenital Heart Diseases, Heart Failure, Pulmonary Hypertension, Heart Function (HF/LVEDP), Pulmonary Artery Pressure (PA), and Others), and End User (Hospitals, Ambulatory Surgery Centers, Cardiac Centers, Home Care, Clinics, and Others)
... Monitor, and Standard Monitor), Application (Coronary Heart Diseases, Sudden Cardiac Arrest, Stroke, Arrhythmia, Congenital Heart Diseases, Heart Failure, Pulmonary Hypertension, Heart Function (HF/LVEDP), Pulmonary Artery Pressure (PA), and Others), and End User (Hospitals, Ambulatory Surgery ... Read More
-
Global Dry Powder Inhaler Market Size study, by Product (Single Dose Dry Powder Inhalers, Multi Dose Dry Powder Inhalers) by Indication (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension, Diabetes, Cystic Fibrosis) by Function (Manually operated Inhaler Devices, digitally operated Inhaler Devices) by end use industries (Institutional Sales, Retail Sales, Mail Order Pharmacies) and Regional Forecasts 2022-2028
... (Manually operated Inhaler Devices, digitally operated Inhaler Devices) by end use industries (Institutional Sales, Retail Sales, Mail Order Pharmacies) and Regional Forecasts 2022-2028Global Dry Powder Inhaler Market is valued approximately USD XX billion in 2021 ... Read More
-
2022-2026 Pneumonia Molecular Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... and sale forecasts for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Pneumonia tests performed in the following market segments: Hospitals Commercial/Private Labs Physician Offices ... Read More
-
2022 Global: In Vitro Lung Model - Innovative Markets Forecast (2028) report
... the period 2017 through 2028. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2017 to 2028 ... Read More
-
2022-2026 Succeeding in the France Respiratory Diseases Diagnostic Market for 9 Tests: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
... presents detailed analysis of the French Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus , Coronavirus , Influenza , Legionella , Mononucleosis , Mycoplasma , Pneumonia , RSV and Tuberculosis . The ... Read More
-
2022-2026 Succeeding in the UK Respiratory Diseases Diagnostic Market for 9 Tests: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
... presents detailed analysis of the UK Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus , Coronavirus , Influenza , Legionella , Mononucleosis , Mycoplasma , Pneumonia , RSV and Tuberculosis . The ... Read More
-
2022-2026 Succeeding in the US Respiratory Diseases Diagnostic Market for 9 Tests: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
... presents detailed analysis of the US Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus , Coronavirus , Influenza , Legionella , Mononucleosis , Mycoplasma , Pneumonia , RSV and Tuberculosis . The ... Read More
-
2022-2026 Succeeding in the Global Pneumonia Testing Market: US, Europe, Japan - Supplier Shares and Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
... Pneumonia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Pneumonia definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales ... Read More
-
2022-2026 Succeeding in the Germany Respiratory Diseases Diagnostic Market for 9 Tests: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
... presents detailed analysis of the German Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus , Coronavirus , Influenza , Legionella , Mononucleosis , Mycoplasma , Pneumonia , RSV and Tuberculosis . The ... Read More
-
2022-2026 Succeeding in the Europe Respiratory Diseases Diagnostic Market for 8 Tests: France, Germany, Italy, Spain, UK - Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
... report from LeadingMarketResearch.com provides analysis of the Europe respiratory disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. About this Report This report presents ... Read More
-
Oxygen Long Term Covid Treatment Equipment: Market Shares, Strategies, and Forecasts, 2022 to 2028
... Forecasts, 2022 to 2028. The 2022 study has 198 pages, 93 tables and figures. Exercise intolerance is responsive to intermittent supplemental oxygen. Oxygen treatments represent next generation automation of helping people who are challenged by ... Read More
Research Assistance
